The safety of dental amalgam in children

Expert Opinion on Drug Safety

Volumn 5, Issue 6, 2006, Pages 773-781

  Martin, Michael D ^a   Woods, James S ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Amalgam; Children; Mercury

Indexed keywords

ANTIBIOTIC AGENT; DENTAL ALLOY; MERCURY;

ANTIBIOTIC RESISTANCE; AUTISM; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILD SAFETY; CLINICAL STUDY; CLINICAL TRIAL; DENTAL CARIES; HEALTH HAZARD; HUMAN; KIDNEY INJURY; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; PEER REVIEW; PUBLISHING; RANDOMIZATION; RATING SCALE; REVIEW; TOOTH FILLING;

CHILD; DENTAL AMALGAM; DENTAL CARIES; HUMANS; MERCURY;

EID: 33750568214     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.5.6.773     Document Type: Review

References (72)

1. CLARKSON TW, FRIBERG L, HURSH JB, NYLANDER M: The prediction of intake of mercury vapor from amalgams. In: Biological Montioring of Toxic Metals. Clarkson TW, Friberg L, Nordberg GF and Sager PR (Eds) Plenum Press, New York, USA (1988):247-264.
2. AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY: Toxicological Profile for Mercury. Atlanta, GA, US Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, March 1999.
3. CLARKSON TW, MAGOS L, MYERS GL: The toxicology of mercury-current exposures and clinical manifestations. N. Engl. J. Med. (2003) 349:1731-1737.
4. SATOH H: Occupational and environmental toxicology of mercury and its compounds. Ind. Health (2000) 38:153-164.
5. CIANCIOLA ME, ECHEVERRIA D, MARTIN MD, APOSIAN HV, WOODS JS: Epidemiologic assessment of measures used to indicate low-level exposure to mercury vapor (Hg). J. Toxicol. Environ. Health (1997) 52:19-33.
6. 0 among dental professionals: a cross-study evaluation of psychomotor effects. Neurotoxicol. Teratol. (1998) 20:429-439.
7. WOODS JS, MARTIN MD, LEROUX BG: Validity of spot urine samples as a surrogate measure of 24-hour porphyrin excretion rates. Evaluation of diurnal variations in porphyrin, mercury, and creatinine concentrations among subjects with very low occupational mercury exposure. J. Occup. Environ. Med. (1998) 40:1090-101.
8. WOODS JS: Mercury and the central nervous system. Environ. Health Perspect. (2002) 10:A177.
9. ECHEVERRIA D, APOSHIAN HV, WOODS JS et al.: Neurobehavioral effects from exposure to dental amalgam Hg(o): new distinctions between recent exposure and Hg body burden. FASEB J. (1998) 12:971-980.
10. AYDIN N, KARAOGLANOGLU S, YIGIT A, KELES MS, KIRPINAR I, SEVEN N: Neuropsychological effects of low mercury exposure in dental staff in Erzurum, Turkey. Int. Dent. J. (2003) 53:85-91.
11. ECHEVERRIA D, WOODS JS, HEYER NJ et al.: The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans. Neurotoxicol. Teratol. (2006) 28:39-48.
12. RITCHIE KA, GILMOUR WH, MACDONALD EB et al.: Health and neuropsychological functioning of dentists exposed to mercury. Occup. Environ. Med. (2002) 59:287-293.
13. SAXE SR, SNOWDON DA, WEKSTEIN MW et al.: Dental amalgam and cognitive function in older women: findings from the Nun Study. J. Am. Dent. Assoc. (1995) 126:1495-501.
14. BJORKMAN L, PEDERSEN NL, LICHTENSTEIN P: Physical and mental health related to dental amalgam fillings in Swedish twins. Comm. Dent. Oral Epidemiol. (1996) 24:260-267.
15. SAXE SR, WEKSTEIN MW, KRYSCIO RJ et al.: Alzheimer's disease, dental amalgam and mercury. J. Am. Dent. Assoc. (1999) 130:191-199.
16. NITSCHKE I, MULLER F, SMITH J, HOPFENMULLER W: Amalgam fillings and cognitive abilities in a representative sample of the elderly population. Gerodontology (2000) 17:39-44.
17. LANGWORTH S, BJORKMAN L, ELINDER CG, SAVLIN P: Multidisciplinary examination of patients with illness attributed to dental fillings. J. Oral Rehabil. (2002) 29:705-713.
18. DALEN K, LYGRE GB, KLOVE H, GJERDET NR, ASKEVOLD E: Memory functions in persons with dental amalgam. J. Dent. (2003) 31:487-492.
19. FACTOR-LITVAK P, HASSELGREN G, JACOBS D et al.: Mercury derived from dental amalgams and neuropsychologic function. Environ. Health Perspect. (2003) 111:719-723.
20. KINGMAN A, ALBERS JW, AREZZO JC, GARABRANT DH, MICHALEK JE: Amalgam exposure and neurological function. Neurotoxicology (2005) 26:241-255.
21. WEIL M, BRESSLER J, PARSONS P, BOLLA K, GLASS T, SCHWARTZ B: Blood mercury levels and neurobehavioral function. JAMA (2005) 293:1875-1882.
22. LANGWORTH S, ELINDER CG, SUNDQVIST KG: Minor effects of low exposure to inorganic mercury on the human immune system. Scand. J. Work. Environ. Health. (1993) 19:405-413.
23. MUTTER J, NAUMANN J, SADAGHAIANI C, SCHNEIDER R, WALACH H: Alzheimer's disease: mercury as a pathogenetic factor and apolipoprotein E as a moderator. Neuroendocrinol. Lett. (2004) 25:331-339.
24. BATES MN, FAWCETT J, GARRETT N, CUTRESS T, KJELLSTROM T: Health effects of dental amalgam exposure: a retrospective cohort study. Int. J. Epidemiol. (2004) 33:894-902.
25. AMERICAN DENTAL ASSOCIATION: 1999 Survey of Dental Services Rendered. Chicago, IL, USA: ADA Survey Center (2002).
26. BROWNAWELL AM, BERENT S, BRENT RL et al.: The potential adverse health effects of dental amalgam. Toxicol. Rev. (2005) 24:1-10.
27. MARTIN MD, NALEWAY C, CHOU HN: Factors contributing to mercury exposure in dentists. J. Am. Dent. Assoc. (1995) 126:1502-1511.
28. BERGLUND A, MOLIN M: Mercury vapor release from dental amalgam in patients with symptoms allegedly caused by amalgam fillings. Eur. J. Oral Sci. (1996) 104:56-63.
29. SALLSTEN G, THOREN J, BARREGARD L, SCHUTZ A, SKARPING G: Long-term use of nicotine chewing gum and mercury exposure from dental amalgam fillings. J. Dent. Res. (1996) 75:594-598.
30. KINGMAN A, ALBERTINI T, BROWN LJ: Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J. Dent. Res. (1998) 77:461-471.
31. CLARKSON TW: The three modern faces of mercury. Environ. Health Perspect. (2002) 110(Suppl. 1):11-23.
32. MARTIN MD, LEROUX BG, BENTON T et al.: Longitudinal assessments of urinary mercury levels in the Casa Pia study. J. Dent. Res. (2002) 81(SI):3445.
33. MARTIN MD, LEROUX B, WOODS JS et al.: The effect of creatinine adjustment on urinary mercury values in children in a longitudinal study. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. (2005) 99:427.
34. MACKERT JR Jr: Mercury exposure from dental amalgam filling: absorbed dose and the potential for adverse health effects. Crit. Rev. Oral Biol. Med. (1997) 8:410-436.
35. LEVY M, SCHWARTZ S, DIJAK M, WEBER JP, TARDIF R, ROUAH F: Childhood urine mercury excretion: dental amalgam and fish consumption as exposure factors. Environ. Res. (2004) 94:283-290.
36. KHORDI-MOOD M, SARRAF-SHIRAZI AR, BALALI-MOOD M: Urinary mercury excretion following amalgam filling in children. J. Toxicol. Clin. Toxicol. (2001) 39:701-705.
37. SUMMERS AO, WIREMAN J, VIMY MJ et al.: Mercury released from dental 'silver' fillings provokes an increase in mercury-and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob. Agents Chemother. (1993) 37:825-834.
38. LORSCHEIDER FL, VIMY MJ, SUMMERS AO, ZWIERS H: The dental amalgam mercury controversy-inorganic mercury and the CNS; genetic linkage of mercury and antibiotic resistances in intestinal bacteria. Toxicology (1995) 97:19-22.
39. WIREMAN J, LIEBERT CA, SMITH T, SUMMERS AO: Association of mercury resistance with antibiotic resistance in the Gram-negative fecal bacteria of primates. Appl. Environ. Microbiol. (1997) 63:4494-503.
40. OSTERBLAD M, LEISTEVUO J, LEISTEVUO T et al.: Antimicrobial and mercury resistance in aerobic Gram-negative bacilli in fecal flora among persons with and without dental amalgam fillings. Antimicrob. Agents Chemother. (1995) 39:2499-502.
41. EDLUND C, BJORKMAN L, EKSTRAND J, SANDBORGH-ENGLUND G, NORD CE: Resistance of the normal human microflora to mercury and antimicrobials after exposure to mercury from dental amalgam fillings. Clin. Infect. Dis. (1996) 22:944-950.
42. LEISTEVUO J, JARVINEN H, OSTERBLAD M, LEISTEVUO T, HUOVINEN P, TENOVUO J: Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings. Antimicrob. Agents Chemother. (2000) 44:456-457.
43. PIKE R, LUCAS V, STAPLETON P et al.: Prevalence and antibiotic resistance profile of mercury-resistant oral bacteria from children with and without mercury amalgam fillings. J. Antimicrob. Chemother. (2002) 49:777-783.
44. PIKE R, LUCAS V, PETRIE A et al.: Effect of restoration of children's teeth with mercury amalgam on the prevalence of mercury- and antibiotic-resistant oral bacteria. Microb. Drug Resist. (2003) 9:93-97.
45. READY D, LANCASTER H, MULLANY P, BEDI R, WILSON M: Antibiotic resistance in the cultivable plaque microbiota of children from different ethnic groups. Int. J. Antimicrob. Agents (2006) 27:376-382.
46. GEIER DA, GEIER MR: A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis. Med. Sci. Monit. (2005) 11:CR160-CR170.
47. ANDREWS N, MILLER E, GRANT A, STOWE J, OSBORNE V, TAYLOR B: Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association. Pediatrics (2004) 114:584-591.
48. IP P, WONG V, HO M, LEE J, WONG W: Mercury exposure in children with autistic spectrum disorder: case-control study. J. Child. Neurol. (2004) 19:431-434.
49. PARKER S, TODD J, SCHWARTZ B, PICKERING L: Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics (2005) 115:200.
50. HOLMES AS, BLAXILL MF, HALEY BE: Reduced levels of mercury in first baby haircuts of autistic children. Int. J. Toxicol. (2003) 22:277.
51. IMMUNIZATION SAFETY REVIEW COMMITTEE, INSTITUTE OF MEDICINE: Of the National Academies: Immunization Safety Review. Vaccines and Autism. The National Academies Press, Washington, DC, USA (2004).
52. DEROUEN TA, LEROUX BG, MARTIN MD et al.: Issues in design and analysis of a randomized clinical trial to assess the safety of dental amalgam restorations in children. Control. Clin. Trials (2002) 23:301-320.
53. DEROUEN TA, MARTIN MD, LEROUX BG et al.: Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. JAMA (2006) 295:1784-1792.
54. O'BRIEN PC: Procedures for comparing samples with multiple endpoints. Biometrics (1984) 40:1079-1087.
55. LEROUX BG, MANCL LA, DEROUEN TA: A sequential design for studies with repeated measures on multiple outcomes. Cont. Clin. Trials (1997) 18:109S.
56. BELLINGER DC, TRACHTENBERG F, BARREGARD L et al.: Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA (2006) 295:1775-1778.
57. CHILDREN'S AMALGAM TRIAL STUDY GROUP: The Children's Amalgam Trial: design and methods. Cont. Clin. Trials (2003) 24:795-814.
58. NEEDLEMAN HL: Mercury in dental amalgam - a neurotoxic risk? JAMA (2006) 295:1835-1836.
59. MJOR IA, DAHL JE, MOORHEAD JE: Placement and replacement of restorations in primary teeth. Acta Odontol. Scand. (2002) 60:25-28.
60. SJOGREN P, HALLING A: Survival time of Class II molar restorations in relation to patient and dental health insurance costs for treatment. Swed. Dent. J. (2002) 26:59-66.
61. VAN NIEUWENHUYSEN JP, D'HOORE W, CARVALHO J, QVIST V: Long-term evaluation of extensive restorations in permanent teeth. J. Dent. (2003) 31:395-405.
62. OPDAM NJ, BRONKHORST EM, ROETERS JM, LOOMANS BA: A retrospective clinical study on longevity of posterior composite and amalgam restorations. Dent. Mater. (2006) (Epub ahead of print).
63. WADA H, TARUMI H, IMAZATO S, NARIMATSU M, EBISU S: In vitro estrogenicity of resin composites. J. Dent. Res. (2004) 83:222-226.
64. ISO T, WATANABE T, IWAMOTO T, SHIMAMOTO A, FURUICHI Y: DNA damage caused by bisphenol A and estradiol through estrogenic activity. Biol. Pharm. Bull. (2006) 29:206-210.
65. MAFFINI MV, RUBIN BS, SONNENSCHEIN C, SOTO AM: Endocrine disruptors and reproductive health: The case of bisphenol-A. Mol. Cell. Endocrinol. (2006) 254-255:179-186.
66. RAMILO G, VALVERDE I, LAGO J, VIEITES JM, CABADO AG: Cytotoxic effects of BADGE (bisphenol A diglycidyl ether) and BFDGE (bisphenol F diglycidyl ether) on Caco-2 cells in vitro. Arch. Toxicol. (2006) (Epub ahead of print).
67. MARTIN MD, BAJET D, WOODS JS, DILLS RL, POULTEN EJ: Detection of dental composite and sealant resin components in urine. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. (2005) 99:429.
68. ANNEROTH G, ERICSON T, JOHANSSON I et al.: Comprehensive medical examination of a groups of patients with alleged adverse effects from dental amalgams. Acta Odontol. Scand. (1992) 50:101-111.
69. LANGWORTH S, ELINDER CG, SUNDQUIST KG, VESTERBERG O: Renal and immunological effects of occupational exposure to inorganic mercury. Br. J. Ind. Med. (1992) 49:394-401.
70. ECHEVERRIA D, WOODS JS, HEYER NJ et al.: Chronic low-level mercury exposure, BDNF polymorphism, and associations with cognitive and motor function. Neurotox. Teratol. (2005) 27:781-796.
71. WOODS JS, ECHEVERRIA D, HEYER NJ, SIMMONDS PL, WILKERSON J, FARIN FM: The association between generic porlymophisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans. Toxicol. Appl. Pharmacol. (2005) 206:113-120.
72. CUSTODIO HM, HARARI R, GERHARDSSON L, SKERFVING S, BROBERG K: Genetic influences on the retention of inorganic mercury. Arch. Environ. Occup. Health (2005) 60:17-23.